Nexus Surgical & Medicare
31.95
+1.00(+3.23%)
Market Cap₹16.90 Cr
PE Ratio21.49
Company Performance:
1D+3.23%
1M-4.51%
6M+82.68%
1Y+91.09%
5Y+1,105.66%
View Company Insightsright
More news about Nexus Surgical & Medicare
02Sept 26
Nexus Surgical appoints Ashish Mishra as independent director
Ashish Durgaprasad Mishra appointed as Independent Non-Executive Director. Five-year term runs from September 2, 2026, to September 1, 2031. Appointment requires approval at the 35th Annual General Meeting. Mishra brings expertise in financial oversight and industry regulations.
 no imag found
02Sept 26
Nexus Surgical accepts resignation of MD Ram Swaroop Joshi
Ram Swaroop Joshi resigns as Managing Director of Nexus Surgical and Medicare Ltd. Effective date for the resignation is September 2, 2026. Joshi continues as a Promoter Non-Executive Director with no remuneration. Resignation cited personal reasons with no disagreement on operations.
 no imag found
28May 26
Nexus Surgical appoints M/s. VMRS & Co. as internal auditor for FY27
Nexus Surgical and Medicare Limited has appointed M/s. VMRS & Co., Chartered Accountants, as its internal auditor for the financial year 2026-27. The board approved the appointment on May 28, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 no imag found
08Apr 26
Nexus Surgical And Medicare Limited Submits SEBI Certificate for Q4 FY26
Nexus Surgical And Medicare Limited submitted its Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Q4 FY26 to BSE Limited on 8th April, 2026. The certificate, issued by RTA Purva Sharegistry (India) Private Limited, confirms regulatory compliance and shows no dematerialisation activity during the quarter ended 31st March, 2026.
 no imag found
14Feb 26
Nexus Surgical and Medicare Reports Strong Q3 FY26 Results with 49.76% Profit Growth
Nexus Surgical and Medicare Limited reported strong Q3 FY26 results with net profit of ₹17.01 lakhs, up 49.76% from ₹11.36 lakhs in Q3 FY25. Sales revenue nearly doubled to ₹293.08 lakhs, showing 97.55% growth year-on-year. Nine-month performance remained robust with net profit rising 21.29% to ₹49.62 lakhs and sales growing 37.34% to ₹582.19 lakhs. The company maintained stable capital structure and reported no investor complaints during the quarter.
 no imag found
03Jan 26
Nexus Surgical & Medicare Clarifies Recent Stock Price Movement to BSE
Nexus Surgical & Medicare Limited responded to BSE's surveillance inquiry about recent stock price movements, attributing the volatility to market conditions. The company confirmed compliance with SEBI LODR Regulations 2015 and stated no undisclosed price-sensitive information or pending announcements exist.
 no imag found
14Aug 25
Nexus Surgical & Medicare Reports 70% Jump in Q1 Profit, Revenue Dips Slightly
Nexus Surgical & Medicare Limited reported a significant increase in net profit for Q1 FY2024, rising 69.6% to ₹15.25 lakhs from ₹8.99 lakhs year-over-year. This growth came despite a 2% decrease in total income to ₹172.52 lakhs. The company effectively managed expenses, reducing them by 7.2% to ₹152.15 lakhs. Earnings per share improved by 75% to ₹0.28. Managing Director Ram Swaroop Joshi expressed satisfaction with the company's profitability improvement and efficient expense management.
 no imag found
Nexus Surgical & Medicare
31.95
+1.00
(+3.23%)
1 Year Returns:+91.09%
Industry Peers
Algoquant Fintech
71.44
(+6.04%)
Gyftr
168.81
(-0.32%)
Prime Securities
302.60
(+0.97%)
RNFI Services
332.75
(+0.23%)
Regency Fincorp
64.64
(+18.87%)
Akiko Global Services
407.90
(-0.15%)